2016
DOI: 10.36233/0372-9311-2016-3-24-31
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiological Differentiation of Natural Foci of Hemorrhagic Fever With Renal Syndrome of the Republic of Bashkortostan

Abstract: Aim. Typization of natural foci of HFRS of the Republic of Bashkortostan and differentiation of their territories by the degree of potential epidemic hazard. Materials and methods. Materials of epizootologic and epidemiologic monitoring of natural foci of HFRS of the Republic of Bashkortostan for 1980 - 2014 were used. Evaluation of area of territory with high, medium and low potential epidemic hazard by HFRS was carried out taking into account multi-year parameters of morbidity by administrative districts of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2019
2019

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[6][7][8][9][10][11] The first committed step in this pathway is catalyzed by an essential cytoplasmic acetyl-CoA carboxylase multienzyme complex 12 (see also Supporting Information Text S1), and inhibitors of the BC active site of this complex have shown antibacterial activity against several Gram-negative species. 5,[13][14][15][16][17] The BC active site is highly conserved across a number of bacterial pathogens, including P. aeruginosa, E. coli, and H. influenzae. 18 While 1 lacks the potency to become a therapeutic agent, it is a promising starting point for medicinal chemistry efforts because of its selective on-target activity, low molecular weight, and available co-crystal structures with BC that enable structure-based molecular design.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8][9][10][11] The first committed step in this pathway is catalyzed by an essential cytoplasmic acetyl-CoA carboxylase multienzyme complex 12 (see also Supporting Information Text S1), and inhibitors of the BC active site of this complex have shown antibacterial activity against several Gram-negative species. 5,[13][14][15][16][17] The BC active site is highly conserved across a number of bacterial pathogens, including P. aeruginosa, E. coli, and H. influenzae. 18 While 1 lacks the potency to become a therapeutic agent, it is a promising starting point for medicinal chemistry efforts because of its selective on-target activity, low molecular weight, and available co-crystal structures with BC that enable structure-based molecular design.…”
Section: Introductionmentioning
confidence: 99%